Blood cell energy study could predict ketamine response in depression
NCT ID NCT07399756
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how S-ketamine, a treatment for severe depression, affects tiny energy centers (mitochondria) in blood cells. Researchers will take blood samples from 30 adults with treatment-resistant depression before and after treatment. They hope to find markers that predict who will respond well to the drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sheba Medical Center
Ramat Gan, Israel, 52621, Israel
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a structured care pathway ease teen depression?
- Can a nasal spray break through tough depression?
- Could a new drug offer hope for Treatment-Resistant depression?
- Targeting depression: can MRI-Guided brain zaps rewire key circuits?
- Can a psychedelic trip plus a gentle ear zap lift depression?
- Can a smart brain implant outsmart depression?